AVTX Smart Money
Avalo Therapeutics, Inc.
1W: -45.4%
1M: -55.2%
3M: -64.5%
YTD: -60.3%
1Y: -61.6%
3Y: -77.1%
5Y: -99.9%
$6.75
-0.02 (-0.30%)
Weekly Expected Move ±20.7%
$4
$5
$7
$8
$10
Credit Risk of going bust: lower than 74% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Avalo Therapeutics, Inc. would be worth roughly what it owes.
Total debt $242K against a stock market value of $362.0M.
Distance to default 8.27 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $121K (short-term plus half of long-term), stock volatility 92.2%; Altman Z'' 11.63. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Avalo Therapeutics, Inc. would be worth roughly what it owes.
Total debt $242K against a stock market value of $362.0M.
Distance to default 8.27 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $121K (short-term plus half of long-term), stock volatility 92.2%; Altman Z'' 11.63. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026157
Institutions Holding
+40 vs prior
355.2%
Ownership
+235.89%
58
New
47
Increased
42
Reduced
27
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Sullivan Christopher Ryan | officer: chief financial officer | S-Sale | 12,394 | $16.33 | $202K | Filing |
| 2026-09-10 | Sullivan Christopher Ryan | officer: chief financial officer | S-Sale | 10,185 | $17.62 | $179K | Filing |
| 2026-08-28 | Doyle Mittie | officer: chief medical officer | S-Sale | 679 | $20.00 | $14K | Filing |
| 2026-08-18 | Sullivan Christopher Ryan | officer: chief financial officer | S-Sale | 31,031 | $20.05 | $622K | Filing |
| 2026-08-17 | Sullivan Christopher Ryan | officer: chief financial officer | S-Sale | 37,945 | $19.85 | $753K | Filing |
| 2026-08-17 | Sullivan Christopher Ryan | officer: chief financial officer | S-Sale | 3,749 | $19.94 | $75K | Filing |
| 2026-08-17 | Doyle Mittie | officer: chief medical officer | S-Sale | 1,000 | $20.00 | $20K | Filing |
| 2026-08-11 | Riley Jennifer | officer: chief strategy officer | S-Sale | 2,655 | $19.59 | $52K | Filing |
| 2026-08-10 | Doyle Mittie | officer: chief medical officer | S-Sale | 679 | $20.00 | $14K | Filing |
| 2026-07-27 | Doyle Mittie | officer: chief medical officer | S-Sale | 1,000 | $20.00 | $20K | Filing |
| 2026-06-30 | Doyle Mittie | officer: chief medical officer | S-Sale | 4,654 | $20.00 | $93K | Filing |
| 2026-06-23 | Doyle Mittie | officer: chief medical officer | S-Sale | 1,450 | $18.00 | $26K | Filing |
| 2026-06-10 | VARKI PAUL | officer: chief legal officer | F-Tax Withholding | 1,081 | $13.10 | $14K | Filing |
| 2026-06-10 | Sullivan Christopher Ryan | officer: chief financial officer | F-Tax Withholding | 138 | $13.10 | $2K | Filing |
| 2026-06-10 | Doyle Mittie | officer: chief medical officer | F-Tax Withholding | 1,084 | $13.10 | $14K | Filing |
| 2026-06-10 | Riley Jennifer | officer: chief strategy officer | F-Tax Withholding | 588 | $13.10 | $8K | Filing |
| 2026-05-28 | Doyle Mittie | officer: chief medical officer | S-Sale | 679 | $16.00 | $11K | Filing |
| 2026-05-21 | NEIL GARRY ARTHUR | officer: chief executive officer | A-Grant/Award | 100,200 | $— | $0 | Filing |
| 2026-05-21 | VARKI PAUL | officer: chief legal officer | A-Grant/Award | 24,300 | $— | $0 | Filing |
| 2026-05-21 | Sullivan Christopher Ryan | officer: chief financial officer | A-Grant/Award | 39,900 | $— | $0 | Filing |
| 2026-05-21 | Doyle Mittie | officer: chief medical officer | A-Grant/Award | 43,500 | $— | $0 | Filing |
| 2026-05-21 | Riley Jennifer | officer: chief strategy officer | A-Grant/Award | 34,200 | $— | $0 | Filing |
| 2026-05-15 | Doyle Mittie | officer: chief medical officer | S-Sale | 3,000 | $18.76 | $56K | Filing |
| 2026-05-07 | Sullivan Christopher Ryan | officer: chief financial officer | S-Sale | 18,606 | $24.12 | $449K | Filing |
| 2026-05-06 | VARKI PAUL | officer: chief legal officer | S-Sale | 37,375 | $18.91 | $707K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 5,100,216 | $94M | +2,220,735 | 2026-06-30 | Filing |
| BlackRock, Inc. | 4,365,553 | $81M | +4,038,471 | 2026-06-30 | Filing |
| Deep Track Capital, LP | 3,610,000 | $67M | +3,610,000 | 2026-06-30 | Filing |
| Caligan Partners LP | 3,163,866 | $58M | +1,528,843 | 2026-06-30 | Filing |
| TCG Crossover Management, LLC | 3,017,120 | $56M | +2,278,737 | 2026-06-30 | Filing |
| Affinity Asset Advisors, LLC | 2,900,000 | $54M | +1,559,160 | 2026-06-30 | Filing |
| STATE STREET CORP | 2,889,287 | $53M | +2,817,633 | 2026-06-30 | Filing |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2,498,000 | $46M | +1,582,000 | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 2,387,026 | $44M | +1,470,884 | 2026-06-30 | Filing |
| Avoro Capital Advisors LLC | 2,333,333 | $43M | +923,333 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,264,246 | $42M | +1,544,552 | 2026-06-30 | Filing |
| BVF INC/IL | 2,075,545 | $38M | +442,700 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 1,913,829 | $35M | +1,270,829 | 2026-06-30 | Filing |
| Nantahala Capital Management, LLC | 1,862,250 | $34M | +627,250 | 2026-06-30 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,729,000 | $32M | +875,000 | 2026-06-30 | Filing |
| Soleus Capital Management, L.P. | 1,654,978 | $31M | +1,213,000 | 2026-06-30 | Filing |
| BRAIDWELL LP | 1,629,182 | $30M | +1,629,182 | 2026-06-30 | Filing |
| ALLIANCEBERNSTEIN L.P. | 1,260,689 | $23M | +1,260,689 | 2026-06-30 | Filing |
| UBS Group AG | 1,209,059 | $22M | +67,079 | 2026-06-30 | Filing |
| Logos Global Management LP | 1,150,000 | $21M | +850,000 | 2026-06-30 | Filing |